Association between CYP2E1 genetic polymorphisms and lung cancer risk: A meta-analysis

European Journal of Cancer

Volumn 46, Issue 4, 2010, Pages 758-764

  Wang, Yadong ^a   Yang, Haiyan ^b   Li, Li ^a   Wang, Haiyu ^a   Zhang, Congke ^a   Yin, Gongju ^a   Zhu, Baoyu ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

CYP2E1; Genetic polymorphism; Lung cancer; Meta analysis

Indexed keywords

CYTOCHROME P450 2E1;

ARTICLE; CANCER RISK; CYP2E1 GENE; GENE; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PUBLICATION BIAS;

EID: 76049106404     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.12.010     Document Type: Article

References (55)

1. Voicu-Maceseanu A., Nitu M., Olteanu M., and Bica D. Epidemiology of lung cancer. Pneumologia 56 2 (2007) 78-84
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 59 4 (2009) 225-249
3. Cote M.L., Chen W., Smith D.W., et al. Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 169 7 (2009) 802-814
4. Schabath M.B., Spitz M.R., Hong W.K., et al. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung cancer 37 1 (2002) 35-40
5. Kiyohara C., Yoshimasu K., Shirakawa T., and Hopkin J.M. Genetic polymorphisms and environmental risk of lung cancer: a review. Rev Environ Health 19 1 (2004) 15-38
6. Shields P.G., and Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18 11 (2000) 2309-2315
7. Shah P.P., Singh A.P., Singh M., et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 639 1-2 (2008) 1-10
8. Agundez J.A. Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9 6 (2008) 520-531
9. Carlsten C., Sagoo G.S., Frodsham A.J., Burke W., and Higgins J.P. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 167 7 (2008) 759-774
10. Raimondi S., Paracchini V., Autrup H., et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164 11 (2006) 1027-1042
11. Kiyohara C., Yoshimasu K., Takayama K., and Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med 7 7 (2005) 463-478
12. Le Marchand L., Guo C., Benhamou S., et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14 4 (2003) 339-346
13. Liu Y., Meng X.W., Zhou L.Y., Zhang P.Y., Sun X., and Zhang P. Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities. Hepatobiliary Pancreat Dis Int 8 2 (2009) 162-167
14. Hayashi S., Watanabe J., and Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110 4 (1991) 559-565
15. Oyama T., Kawamoto T., Mizoue T., et al. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res 17 1B (1997) 583-587
16. Uematsu F., Kikuchi H., Motomiya M., et al. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 82 3 (1991) 254-256
17. Hirvonen A., Husgafvel-Pursiainen K., Anttila S., Karjalainen A., and Vainio H. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 14 1 (1993) 85-88
18. Watanabe J., Yang J.P., Eguchi H., et al. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn J Cancer Res 86 3 (1995) 245-248
19. London S.J., Daly A.K., Cooper J., et al. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics 6 2 (1996) 151-158
20. Kato S., Shields P.G., Caporaso N.E., et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 52 23 (1992) 6712-6715
21. Wu X., Shi H., Jiang H., et al. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18 5 (1997) 967-973
22. Marchand L.L., Wilkinson G.R., and Wilkens L.R. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev 8 6 (1999) 495-500
23. Minegishi Y., Tsukino H., Muto M., et al. Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population. Cancer 110 2 (2007) 353-362
24. Lee K.M., Kang D., Lee S.J., et al. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep 16 5 (2006) 1035-1039
25. Hamada G.S., Sugimura H., Suzuki I., et al. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarkers Prev 4 1 (1995) 63-67
26. Shi Y., Zhou X., Zhou Y., and Ren X. Analysis of CYP2E1, GSTM1 Genetic polymorphisms in relation to human lung cancer and esophageal carcinoma. J Huazhong Univ Sci Technol (Health Science) 31 1 (2002) 14-17
27. Ye W., Chen S., Chen Q., Zhang D., and Cai X. Association of CYP2E1 polymorphism and serum selenium level with risk of human lung cancer. Tumor 26 5 (2006) 450-452
28. Zou L., Lv B., Zhang X., Zhou S., Hao Q., and Zhou Y. Effect of CYP2E1 Polymorphism on DNA Stability and Lung Cancer Susceptibility. J Environ Occup Med 21 2 (2004) 81-83
29. Chen S., Yu S., Chen Q., et al. A case-control study of the impact of CYP2E1 RsaI polymorphism on the risk of lung cancer. J Guangdong College Pharm 18 3 (2002) 220-224
30. Li D., Zhou Q., Guo Z., et al. Association between genetic polymorphisms of CYP2E1 and lung cancer susceptibility:a case control study. Acta Academiae Medicinae Militaris Tertiae 30 13 (2008) 1231-1234
31. Huang Y., Wang Q., Zhu L., and Zhang Y. Relationship between cytochrome P450 2E1 genetic polymorphism and lung cancer in Chinese Han subjects. Chin J Clin Pharmacol 16 5 (2000) 350-352
32. Li Z., Tan W., Shao K., Zhang L., and Lin D. Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1. Chin J Oncol 22 1 (2000) 5-7
33. Qu Y., Shi Y., Zhang L., et al. Cytochrome P450 2E1 genetic polymorphism and non-smoking female lung cancer risk. Carcinog Teratogenesis Mutagen 10 6 (1998) 355-358
34. Li W., Lai B., and Zhan X. The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer. Chin J Epidemiol 25 12 (2004) 1042-1045
35. Quinones L., Lucas D., Godoy J., et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174 1 (2001) 35-44
36. Wang S.L., Lee H., Chen K.W., Tsai K.J., Chen C.Y., and Lin P. Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung cancer 26 1 (1999) 27-34
37. Wang J., Deng Y., Li L., et al. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci 94 5 (2003) 448-452
38. Oyama T., Matsumoto A., Isse T., et al. Evidence-based prevention (EBP): approach to lung cancer prevention based on cytochrome 1A1 and cytochrome 2E1 polymorphism. Anticancer Res 23 2C (2003) 1731-1737
39. Persson I., Johansson I., Bergling H., et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett 319 3 (1993) 207-211
40. Persson I., Johansson I., Lou Y.C., et al. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer 81 3 (1999) 325-329
41. El-Zein R.A., Zwischenberger J.B., Abdel-Rahman S.Z., Sankar A.B., and Au W.W. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma. Cancer Lett 112 1 (1997) 71-78
42. Gu Y., Zhang Z., Zhang S., Zheng S., Jia H., and Gu S. Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility. Zhonghua Yi Xue Za Zhi 87 43 (2007) 3064-3068
43. Eom S.Y., Zhang Y.W., Kim S.H., et al. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control 20 2 (2009) 137-145
44. Kato S., Shields P.G., Caporaso N.E., et al. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarkers Prev 3 6 (1994) 515-518
45. Le Marchand L., Sivaraman L., Pierce L., et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58 21 (1998) 4858-4863
46. Wu X., Amos C.I., Kemp B.L., et al. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev 7 1 (1998) 13-18
47. Uematsu F., Kikuchi H., Motomiya M., et al. Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer. Tohoku J Exp Med 168 2 (1992) 113-117
48. Liang G., Pu Y., and Yin L. Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Hereditas 26 5 (2004) 584-588
49. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 3 (1986) 177-188
50. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj 315 7109 (1997) 629-634
51. Shi X., Zhou S., Wang Z., Zhou Z., and Wang Z. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 59 2 (2008) 155-163
52. Watanabe J., Hayashi S., Nakachi K., et al. PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res 18 23 (1990) 7194
53. Tan W., Wu J., Tang H., and Lin D. Expression of cytochrome P4502E1 in human liver: Relationship between genotype and phenotype in Chinese. Sci China C Life Sci 44 4 (2001) 356-364
54. Lucas D., Menez C., Girre C., et al. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5 5 (1995) 298-304
55. Broeks A., Urbanus J.H., Floore A.N., et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66 2 (2000) 494-500